We are live on ! Find out more
Ameriprise

Ameriprise Portfolio holdings

AUM $432B
1-Year Est. Return 30.22%
 

Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.

This Fund
S&P 500
This Quarter Est. Return
+5.18%
1 Year Est. Return
+30.22%
3 Year Est. Return
+89.37%
5 Year Est. Return
+112.58%
10 Year Est. Return
+510.85%
AUM
$169B
AUM Growth
+$2.97B
Cap. Flow
-$5.99B
Cap. Flow %
-3.53%
Top 10 Hldgs %
11.82%
Holding
6,303
New
585
Increased
2,589
Reduced
1,823
Closed
260

Top Buys

Rank Stock Value
1
CTRA
Coterra Energy
CTRA
+$422M
2
MSFT icon
Microsoft
MSFT
+$281M
3
VZ icon
Verizon
VZ
+$274M
4
BP icon
BP
BP
+$223M
5
HPQ icon
HP
HPQ
+$212M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$531M
2
EOG icon
EOG Resources
EOG
+$511M
3
ACN icon
Accenture
ACN
+$320M
4
MELI icon
Mercado Libre
MELI
+$299M
5
LVS icon
Las Vegas Sands
LVS
+$271M

Sector Composition

Rank Sector Weight
1 Technology 14.13%
2 Financials 12.95%
3 Healthcare 12.43%
4 Industrials 10.31%
5 Communication Services 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XYLD icon
4851
Global X S&P 500 Covered Call ETF
XYLD
$3.27B
-100
Closed -$4K
CSCI
4852
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
0
AIFU
4853
AIFU Inc
AIFU
$221M
0
FLG.PRU
4854
Flagstar Bank National Association Bifurcated Option Note Unit Securities
FLG.PRU
$118M
-1
Closed -$2K
CDMO
4855
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$0 ﹤0.01%
+3
New +$38
BIOL
4856
DELISTED
Biolase, Inc.
BIOL
0
GENE
4857
DELISTED
Genetic Technologies Ltd.
GENE
$0 ﹤0.01%
+2
New +$239
MTBL
4858
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
$0 ﹤0.01%
+22
New +$110
ONCT
4859
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
-15
Closed -$32K
FRTX
4860
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
-1
Closed -$2K
QUOT
4861
DELISTED
Quotient Technology Inc
QUOT
-9,789
Closed -$241K
ACGN
4862
DELISTED
Aceragen Inc
ACGN
$0 ﹤0.01%
+1
New +$412
FCRD
4863
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
$0 ﹤0.01%
10
-240
-96% -$3.24K
STAB
4864
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$0 ﹤0.01%
50
+47
+1,567% +$549
CCXI
4865
DELISTED
ChemoCentryx, Inc.
CCXI
$0 ﹤0.01%
+30
New +$168
AMPE
4866
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
0
NPTN
4867
DELISTED
NEOPHOTONICS CORP
NPTN
$0 ﹤0.01%
20
-280
-93% -$1.48K
MBII
4868
DELISTED
Marrone Bio Innovations, Inc.
MBII
$0 ﹤0.01%
+10
New +$113
DRNA
4869
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
-86,678
Closed -$2.45M
FPRX
4870
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$0 ﹤0.01%
20
+10
+100% +$143
ZAGG
4871
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
-30,500
Closed -$141K
CEL
4872
DELISTED
Cellcom Israel, Ltd.
CEL
-304
Closed -$4K
DTQ
4873
DELISTED
DTE ENERGY COMPANY 2012 Series C 5.25% Junior Subordinated Debentures due 2062
DTQ
$0 ﹤0.01%
+9
New +$205
DLR.PRG
4874
DELISTED
DIGITAL REALTY TRUST, INC. 5.875% Series G Cumulative Redeemable Preferred Stock, $0.01 par value
DLR.PRG
$0 ﹤0.01%
+17
New +$370
GMO
4875
DELISTED
General Moly, Inc.
GMO
$0 ﹤0.01%
+190
New +$198

Similar funds

Ameriprise's Q2 2014 Portfolio in Review

As of Q2 2014, Ameriprise held 6,303 positions worth $169B, up 1.8% from $167B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Ameriprise withdrew a net $5.99B in Q2 2014, closing 260 positions and reducing 1,823 holdings. Its most notable exit was A T M I INC, an estimated $24.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Ameriprise opened a new position in Navient worth $82.6M.

  • Ameriprise's largest Q2 2014 buy was Navient: 4,664,421 shares worth $82.6M.
  • Ameriprise added most to Coterra Energy in Q2 2014, an estimated $422M increase.
  • Ameriprise's biggest Q2 2014 reduction was JPMorgan Chase, cutting an estimated $531M.
  • Ameriprise fully exited A T M I INC in Q2 2014, selling an estimated $24.3M.
  • Ameriprise's ten largest holdings make up 12% of its $169B portfolio in Q2 2014.
  • Ameriprise opened 585 new positions and closed 260 in Q2 2014.
  • Ameriprise's portfolio value rose 1.8% quarter-over-quarter to $169B.

Based on Ameriprise's 13F filing for Q2 2014, filed 13 Aug 2014.